Liu, Ju

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 625

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Nair, J. K., Attarwala, H., Sehgal, A., Wang, Q., Aluri, K., Zhang, X., Gao, M., Liu, J., Indrakanti, R., Schofield, S., et al. (2017) · Nucleic Acids Research

RNA Interference and Gene DeliveryDNA and Nucleic Acid Chemistry

Cited by 278

E-selectin in vascular pathophysiology

Zhang, J., Huang, S., Zhu, Z., Gatt, A., & Liu, J. (2024) · Frontiers in Immunology

Cell Adhesion Molecules ResearchInflammation biomarkers and pathways

Cited by 79

Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesis

Liu, J., Dong, F., & Hoh, J. (2015) · Proceedings of the National Academy of Sciences

Cerebrovascular and genetic disordersTGF-β signaling in diseases

Cited by 9

Dihydroartemisinin protects blood–brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1

Liu, F., Liu, J., Xiang, H., Sun, Z., Li, Y., Li, X., Liu, Y., & Liu, J. (2022) · Clinical and Experimental Pharmacology and Physiology

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 9

Systematically identifying genetic signatures including novel SNP-clusters, nonsense variants, frame-shift INDELs, and long STR expansions that potentially link to unknown phenotypes existing in dog breeds

Li, Z., Wang, Z., Chen, Z., Voegeli, H., Lichtman, J. H., Smith, P., Liu, J., DeWan, A. T., & Hoh, J. (2023) · BMC Genomics

Genetic and phenotypic traits in livestockHuman-Animal Interaction Studies

Cited by 2